DK0527283T3 - Levnedsmiddelsammensætning - Google Patents

Levnedsmiddelsammensætning

Info

Publication number
DK0527283T3
DK0527283T3 DK91810629T DK91810629T DK0527283T3 DK 0527283 T3 DK0527283 T3 DK 0527283T3 DK 91810629 T DK91810629 T DK 91810629T DK 91810629 T DK91810629 T DK 91810629T DK 0527283 T3 DK0527283 T3 DK 0527283T3
Authority
DK
Denmark
Prior art keywords
food composition
mgf
humans
beta
animals
Prior art date
Application number
DK91810629T
Other languages
Danish (da)
English (en)
Inventor
Anthony C Huggett
Anne Hughes
Edwardo Schiffrin
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0527283T3 publication Critical patent/DK0527283T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Grain Derivatives (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91810629T 1991-08-12 1991-08-12 Levnedsmiddelsammensætning DK0527283T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810629A EP0527283B1 (fr) 1991-08-12 1991-08-12 Composition alimentaire

Publications (1)

Publication Number Publication Date
DK0527283T3 true DK0527283T3 (da) 1998-08-10

Family

ID=8208868

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91810629T DK0527283T3 (da) 1991-08-12 1991-08-12 Levnedsmiddelsammensætning

Country Status (12)

Country Link
US (1) US5461033A (fr)
EP (1) EP0527283B1 (fr)
JP (1) JP2784297B2 (fr)
KR (1) KR930003844A (fr)
AT (1) ATE160486T1 (fr)
AU (1) AU658900B2 (fr)
BR (1) BR9203106A (fr)
DE (1) DE69128283T2 (fr)
DK (1) DK0527283T3 (fr)
ES (1) ES2110986T3 (fr)
GR (1) GR3025647T3 (fr)
PT (1) PT100766B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
FR2684383B1 (fr) * 1991-12-02 1994-03-11 Institut Nal Sante Recherc Medic Cytokine agoniste de l'ifn-gamma.
WO1994009651A1 (fr) * 1992-10-30 1994-05-11 Cancer Research Fund Of Contra Costa Produit antidiarrheique et procede de traitement d'infections associees a des rotavirus
EP0686396B1 (fr) * 1994-02-25 2000-09-27 Societe Des Produits Nestle S.A. Composition entérale comprenant de la caséine micellaire native
AUPM534794A0 (en) * 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
AU702002B2 (en) * 1994-04-28 1999-02-11 Novozymes Biopharma Dk A/S Modified milk growth factor
AU689719B2 (en) * 1995-05-02 1998-04-02 Novozymes Biopharma Dk A/S Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
DE69719190D1 (de) * 1996-07-02 2003-03-27 Pharmaproducts Uk Ltd Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
GB9619634D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
CA2223198A1 (fr) * 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition pour le traitement des inflammations du tractus gastro-intestinal avec methode d'utilisation
EP0852913A1 (fr) * 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Composition et méthode de traitement des affections inflammatoires du tractus gastro-intestinal
WO1998031793A2 (fr) * 1997-01-15 1998-07-23 The Rowett Research Institute Proprietes immunomodulatrices des sequences aminoacide et nucleotidique du facteur de croissance derive du colostrum
EP0875155A1 (fr) * 1997-05-01 1998-11-04 N.V. Nutricia Boisson périoperatif
US5965465A (en) * 1997-09-18 1999-10-12 International Business Machines Corporation Etching of silicon nitride
AUPP031897A0 (en) * 1997-11-12 1997-12-04 Gropep Pty Ltd Mammalian milk growth factor
FR2827290B1 (fr) 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
JP2005522986A (ja) * 2001-10-19 2005-08-04 ジェネンテック・インコーポレーテッド 炎症性腸疾患の診断と治療のための組成物と方法
WO2003057257A1 (fr) * 2002-01-02 2003-07-17 The Johns Hopkins University La cc10 en tant qu'inhibiteur de cytokines et d'eotaxines impliquees dans les maladies allergiques
AU2004219603A1 (en) * 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
EP1675480B1 (fr) 2003-10-16 2018-06-13 Nestec S.A. Composition nutritionnelle contre les effets secondaires de la chimiotherapie ou de la radiotherapie
US7763257B2 (en) 2004-12-09 2010-07-27 Christina Juneau Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products
US20060127493A1 (en) * 2004-12-09 2006-06-15 Yves Pouliot Composition for treating psoriasis
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US7744895B2 (en) 2005-08-31 2010-06-29 Yamanashi University Methods of treating allergies using TGF-β1 and allergens
JP5167480B2 (ja) * 2005-08-31 2013-03-21 国立大学法人山梨大学 アレルギー予防方法又は治療方法、飲食品、並びに経口医薬品
US20090186034A1 (en) * 2006-12-19 2009-07-23 Genetech, Inc. Gene expression markers for inflammatory bowel disease
KR20100056515A (ko) 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드의 용도
EP2190450A2 (fr) 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Utilisation de l'hormone de concentration de la mélanine et de la met-enkephaline comme agents thérapeutiques
AU2008310007A1 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Combination of splenopentin and thymopentin and the use thereof in medicine
CA2698980A1 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent therapeutique
WO2009033739A2 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide comme agent thérapeutique
RU2010114039A (ru) 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение октреотида в качестве терапевтического средства
WO2009033741A2 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide comme agent thérapeutique
JP2010539057A (ja) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのヒト膵臓ポリペプチドの使用
EP2197471A2 (fr) 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Utilisation des peptides maippkknqdk (cow kappa casein 106-116) et/ou ygfqna (serorphin) comme agents therapeutiques
WO2009033781A2 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
RU2010114038A (ru) 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение адреномедуллина в качестве терапевтического средства для лечения избыточного ангиогенеза
RU2010114018A (ru) 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение пептид тимозина бета 4 индивидуально или в сочетании с цекропином а в качестве терапевтического средства
WO2009033661A2 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
JP5395794B2 (ja) 2007-09-11 2014-01-22 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのガラニンペプチドの使用
AU2008306131A1 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of band 3 protein and PACAP-27 as a therapeutic agent
WO2009033792A2 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
WO2009046881A1 (fr) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
KR20100071983A (ko) 2007-09-11 2010-06-29 몬도바이오테크 래보래토리즈 아게 항―ｈｉｖ제로서의 ｒｇｄ－펩티드 및／또는 부갑상선 호르몬（１－３４）의 용도
WO2009033790A2 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
WO2009040051A2 (fr) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
CA2698682A1 (fr) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent therapeutique
US20090072409A1 (en) * 2007-09-14 2009-03-19 International Business Machines Corporation Interconnect Structures Incorporating Air-Gap Spacers
US20090075470A1 (en) * 2007-09-14 2009-03-19 International Business Machines Corporation Method for Manufacturing Interconnect Structures Incorporating Air-Gap Spacers
AU2008334095A1 (en) 2007-11-29 2009-06-11 Genentech, Inc. Gene expression markers for inflammatory bowel disease
JP2012501977A (ja) 2008-09-09 2012-01-26 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのペプチドの使用
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
AU2010276392A1 (en) 2009-07-20 2012-03-08 Genentech, Inc. Gene expression markers for Crohn's disease
US9066526B2 (en) * 2009-10-16 2015-06-30 Dairy Australia Limited Allergy treatment using acid treated aqueous whey protein extract
WO2012071436A1 (fr) 2010-11-24 2012-05-31 Genentech, Inc. Procédé de traitement de maladies inflammatoires autoimmunes utilisant des mutants perte de fonction il-23r
JP5890100B2 (ja) 2011-02-09 2016-03-22 雪印メグミルク株式会社 皮膚コラーゲン産生促進剤
BR112015001884B1 (pt) * 2012-07-31 2020-12-01 Société des Produits Nestlé S.A. composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440860A (en) * 1980-01-18 1984-04-03 The Children's Medical Center Corporation Stimulating cell growth
EP0269408A3 (fr) * 1986-11-26 1989-08-30 Genentech, Inc. TGF-Bêta pour le traitement de maladies inflammatoires
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
GB8723094D0 (en) * 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
WO1990000900A1 (fr) * 1988-07-20 1990-02-08 Amgen Inc. Procede de traitement de troubles inflammatoires par reduction de l'activation phagocytaire
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.

Also Published As

Publication number Publication date
JP2784297B2 (ja) 1998-08-06
DE69128283T2 (de) 1998-03-19
EP0527283A1 (fr) 1993-02-17
KR930003844A (ko) 1993-03-22
JPH05284936A (ja) 1993-11-02
DE69128283D1 (de) 1998-01-08
ATE160486T1 (de) 1997-12-15
AU1952192A (en) 1993-02-18
EP0527283B1 (fr) 1997-11-26
BR9203106A (pt) 1993-03-30
GR3025647T3 (en) 1998-03-31
PT100766B (pt) 1999-10-29
US5461033A (en) 1995-10-24
ES2110986T3 (es) 1998-03-01
AU658900B2 (en) 1995-05-04
PT100766A (pt) 1993-09-30

Similar Documents

Publication Publication Date Title
DE69128283D1 (de) Nahrungsmittelzusammensetzung
FI864559A0 (fi) Nya insulinderivat och farmaceutiska preparat innehaollande dessa derivat.
IL101348A0 (en) Polyethylene glycol protein conjugates,their preparation and pharmaceutical compositions containing them
ATE197053T1 (de) Humaner rezeptor fc(gamma)riii
NO932867L (no) Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene
ATE151278T1 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
DK88385D0 (da) Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler
ES2103987T3 (es) Usos de acidos grasos alfa-hidroxilados.
GR3032543T3 (en) Signal transmission and tag power consumption measurement circuit for an inductive reader.
DK398683D0 (da) Fremgangsmade til fremstilling af antistoffer
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
AU666482B2 (en) Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
IT1264637B1 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro equino
IT1053845B (it) Procedimento per l arricchimento di prodotti agricoli in proteine e vitamine
ATE252325T1 (de) Antioxidative zusammensetzungen mit süssmolkekonzentrat und casein
IT1265252B1 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro bovino.
ITMI930118A0 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro o latte di equino